Risk factor
Low price volatility
Profitability factor
Weak growth
About
UnitedHealth Group Incorporated is a broad-based healthcare enterprise operating within the United States. Established in Minnetonka, Minnesota, in 1974, the company delivers its wide array of services through four distinct divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare division delivers a spectrum of health benefit plans and related services designed for various client types, including large corporations, government entities, small to medium-sized businesses, and individuals. Its offerings encompass specialized care for seniors (aged 50 and above), comprehensive Medicaid programs, children's health coverage, and essential health and dental benefits, alongside hospital and clinical services, often tailored for state-sponsored programs aiding vulnerable populations, including the economically disadvantaged, medically underserved, and those lacking employer-sponsored coverage. Optum Health focuses on providing integrated health and wellness solutions. This segment offers direct care delivery, comprehensive care management, proactive wellness initiatives, consumer engagement tools, and financial services for health. Its clientele spans individual patients, healthcare providers, delivery systems, employers, insurance payers, and government bodies. Optum Insight serves the healthcare industry with analytical and technological solutions. It provides cutting-edge software, valuable information products, strategic advisory consulting, and outsourced managed services. Its clients include hospital networks, medical professionals, health insurers, governmental organizations, biotechnology firms, and other related enterprises. Optum Rx manages pharmacy benefit services, encompassing a wide range of offerings. These include establishing retail pharmacy networks, offering convenient home delivery and specialized pharmacy options, infusion services, and leveraging strong purchasing power with advanced clinical expertise. Furthermore, this segment develops and implements critical programs in areas such as step therapy, formulary management, medication adherence, and disease-specific drug therapy management.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV/EBITDA,